Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 3;8(2):e2460729.
doi: 10.1001/jamanetworkopen.2024.60729.

Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season

Ethan A Litman  1   2 , Tina Yi Jin Hsieh  1 , Anna M Modest  1   2 , Kathleen Clarke  1 , Melissa Dzinoreva  1 , Valerie Perrinez  3 , Esther Apraku Bondzie  3 , Lydia Gallup  3 , Eleanor Schonberg  1   3 , Marjorie Rowe  3 , K'ara Locke  1 , Oluwaseyi Oginni  3 , Robert Jones  1 , Chloe A Zera  1   2 , Ai-Ris Y Collier  1   2   3
Affiliations

Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season

Ethan A Litman et al. JAMA Netw Open. .
No abstract available

Plain language summary

This cohort study evaluates the use rate of respiratory syncytial virus (RSV) vaccines to prevent RSV-related lower respiratory tract disease among infants.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Zera reported receiving grants from CVS Health Foundation and Donoghue Foundation outside the submitted work. Dr Collier reported receiving grants from the National Institutes of Health (NIH), Massachusetts Consortium for Pathogen Readiness, and William F. Milton Foundation/Harvard University during the conduct of the study and research contracts from Pfizer and Sanofi outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Infant Immunization Status and Location by Birth Month Ascertained at the End of the 2023 to 2024 Respiratory Syncytial Virus (RSV) Season
The number of pregnant individuals who delivered between September 1, 2023, and January 31, 2024, was 1899. The number of live-born infants born between September 1, 2023, and January 31, 2024, was 1940.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention . RSVVaxView: data and charts. March 8, 2024. Accessed March 28, 2024. https://www.cdc.gov/rsvvaxview/dashboard/index.html#cdc_data_surveillanc...
    1. Fleming-Dutra KE, Jones JM, Roper LE, et al. . Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(41):1115-1122. doi:10.15585/mmwr.mm7241e1 - DOI - PMC - PubMed
    1. Jones JM, Fleming-Dutra KE, Prill MM, et al. . Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(34):920-925. doi:10.15585/mmwr.mm7234a4 - DOI - PMC - PubMed
    1. Shephard HM, Manning SE, Nestoridi E, et al. . Inequities in COVID-19 vaccination coverage among pregnant persons, by disaggregated race and ethnicity—Massachusetts, May 2021-October 2022. MMWR Morb Mortal Wkly Rep. 2023;72(39):1052-1056. doi:10.15585/mmwr.mm7239a2 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Vaccine Safety Datalink. Accessed June 1, 2024. https://www.cdc.gov/rsvvaxview/dashboard/pregnant-persons-coverage.html